August 26, 2019

The OIG conducted an audit of a pharmacy to determine whether it properly billed the Vendor Drug Program and complied with contractual and state requirements.

The OIG audit evaluated Best Med to determine whether it properly billed the Vendor Drug Program for Medicaid claims submitted, complied with contractual and state requirements, and evaluated IT general controls to determine whether data used for audit testing was reliable. The audit concluded Best Med should return $96,892 to the State of Texas. Read the full report here.